Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
8.77
-0.36 (-3.94%)
Mar 24, 2026, 4:00 PM EDT - Market closed
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $2.97 billion as of March 24, 2026. Its market cap has decreased by -48.37% in one year.
Market Cap
2.97B
Enterprise Value
3.30B
1-Year Change
-48.37%
Ranking
Category
Stock Price
$8.77
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $2.97B, an increase of 2,477.34%. That is a compound annual growth rate of 47.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 2.96B | 17.00% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 3.36B |
| Denali Therapeutics | 3.34B |
| ADMA Biologics | 3.24B |
| Edgewise Therapeutics | 3.20B |
| Legend Biotech | 3.19B |
| Alumis | 2.97B |
| Dyne Therapeutics | 2.95B |
| Vera Therapeutics | 2.91B |